Literature DB >> 6761866

Ifosfamide: European perspective.

H Burkert.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6761866

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

Authors:  C Manegold; P Worst; J Bickel; H Schmid; P Drings; M Kaufmann
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Haemangiosarcoma of the breast.

Authors:  M M Issa; T M Feeley; W H Beesley; P A Daly; C J Cullinane
Journal:  Ir J Med Sci       Date:  1987-02       Impact factor: 1.568

3.  A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas.

Authors:  C Tropé; J Kaern; I Vergote; S Vossli
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.

Authors:  R D Issels; J Mittermüller; A Gerl; W Simon; A Ortmaier; C Denzlinger; H Sauer; W Wilmanns
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.